Running summarizing tools on a new article
Check the paper below, then start its synthesis.
Trajectory of Viral RNA Load Among Persons With Incident SARS-CoV-2 G614 Infection (Wuhan Strain) in Association With COVID-19 Symptom Onset and Severity
Helen C. Stankiewicz Karita (University of Washington), Tracy Qi Dong (Fred Hutch Cancer Center), Christine Johnston (University of Washington, Fred Hutch Cancer Center), Kathleen Maletic Neuzil (University of Maryland, Baltimore), Michael K. Paasche‐Orlow (Boston University, Boston Medical Center), PATRICIA J. KISSINGER (Tulane University), Anna Bershteyn (New York University), Lorna E. Thorpe (New York University), Meagan E. Deming (University of Maryland, Baltimore), Angelica C Kottkamp (New York University), Miriam K. Laufer (University of Maryland, Baltimore), Raphael J. Landovitz (University of California, Los Angeles), Alfred Luk (Tulane University), Risa M. Hoffman (University of Maryland, Baltimore, University of California, Los Angeles), Pavitra Roychoudhury (University of Washington, Fred Hutch Cancer Center), Craig A. Magaret (University of Washington, Fred Hutch Cancer Center), Alexander L. Greninger (University of Washington, Fred Hutch Cancer Center), Meei-Li W. Huang (Fred Hutch Cancer Center), Keith R. Jerome (University of Washington, Fred Hutch Cancer Center), Mark H. Wener (University of Washington), Connie Celum (University of Washington), Helen Y. Chu (University of Washington), Jared M. Baeten (University of Washington), Anna Wald (University of Washington, Fred Hutch Cancer Center), Ruanne V. Barnabas (University of Washington), Elizabeth R. Brown (University of Washington, Fred Hutch Cancer Center), the Hydroxychloroquine COVID-19 PEP Study Team
Abstract: Importance: The SARS-CoV-2 viral trajectory has not been well characterized in incident infections. These data are needed to inform natural history, prevention practices, and therapeutic development. Objective: To characterize early SARS-CoV-2 viral RNA load (hereafter referred to as viral load) in individuals with incident infections in association with COVID-19 symptom onset and severity. Design, Setting, and Participants: This prospective cohort study was a secondary data analysis of a remotely conducted study that enrolled 829 asymptomatic community-based participants recently exposed (<96 hours) to persons with SARS-CoV-2 from 41 US states from March 31 to August 21, 2020. Two cohorts were studied: (1) participants who were SARS-CoV-2 negative at baseline and tested positive during study follow-up, and (2) participants who had 2 or more positive swabs during follow-up, regardless of the initial (baseline) swab result. Participants collected daily midturbinate swab samples for SARS-CoV-2 RNA detection and maintained symptom diaries for 14 days. Exposure: Laboratory-confirmed SARS-CoV-2 infection. Main Outcomes and Measures: The observed SARS-CoV-2 viral load among incident infections was summarized, and piecewise linear mixed-effects models were used to estimate the characteristics of viral trajectories in association with COVID-19 symptom onset and severity. Results: A total of 97 participants (55 women [57%]; median age, 37 years [IQR, 27-52 years]) developed incident infections during follow-up. Forty-two participants (43%) had viral shedding for 1 day (median peak viral load cycle threshold [Ct] value, 38.5 [95% CI, 38.3-39.0]), 18 (19%) for 2 to 6 days (median Ct value, 36.7 [95% CI, 30.2-38.1]), and 31 (32%) for 7 days or more (median Ct value, 18.3 [95% CI, 17.4-22.0]). The cycle threshold value has an inverse association with viral load. Six participants (6%) had 1 to 6 days of viral shedding with censored duration. The peak mean (SD) viral load was observed on day 3 of shedding (Ct value, 33.8 [95% CI, 31.9-35.6]). Based on the statistical models fitted to 129 participants (60 men [47%]; median age, 38 years [IQR, 25-54 years]) with 2 or more SARS-CoV-2-positive swab samples, persons reporting moderate or severe symptoms tended to have a higher peak mean viral load than those who were asymptomatic (Ct value, 23.3 [95% CI, 22.6-24.0] vs 30.7 [95% CI, 29.8-31.4]). Mild symptoms generally started within 1 day of peak viral load, and moderate or severe symptoms 2 days after peak viral load. All 535 sequenced samples detected the G614 variant (Wuhan strain). Conclusions and Relevance: This cohort study suggests that having incident SARS-CoV-2 G614 infection was associated with a rapid viral load peak followed by slower decay. COVID-19 symptom onset generally coincided with peak viral load, which correlated positively with symptom severity. This longitudinal evaluation of the SARS-CoV-2 G614 with frequent molecular testing serves as a reference for comparing emergent viral lineages to inform clinical trial designs and public health strategies to contain the spread of the virus.